Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
Ecolab Inc. (ECL) reported an insider equity award for an executive. EVP & President – Global Markets Alexander A. De Boo received an employee stock option to buy 4,872 shares of Ecolab common stock at an exercise price of $268.515 per share, granted on 12/03/2025. The option becomes exercisable in stages: one-third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, with the first exercisable date shown as 12/03/2026. The option expires on 12/03/2035. Following this grant, the executive reports 5,725.604 shares of Ecolab common stock held directly, along with the new option position of 4,872 derivative securities.
Ecolab Inc. executive Benjamin M. Clark, EVP - Global Supply Chain, reported new equity compensation and updated share holdings. On December 3, 2025, he received an employee stock option to buy 4,872 shares of Ecolab common stock at an exercise price of $268.515 per share. The option becomes exercisable on a cumulative basis: one‑third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, with the first exercisable date listed as December 3, 2026 and an expiration date of December 3, 2035.
The filing also notes that Clark’s end-of-period holdings include 2 additional shares acquired through dividend reinvestment on August 11, 2025, and shows 82.581 shares of Ecolab common stock held directly.
Ecolab Inc. reported an equity compensation update for executive vice president of corporate strategy and business development Harpreet Saluja. On 12/03/2025, the executive received an employee stock option grant for 5,954 shares of common stock at an exercise price of $268.515 per share, which becomes exercisable in three annual installments starting 12/03/2026 and ending 12/03/2035.
On 12/04/2025, the first tranche of a prior grant of 3,993 restricted stock units from December 2024 vested, converting 1,331 units into common stock on a one-for-one basis. To cover minimum statutory tax obligations, 407.286 shares were withheld at a price of $263.385 per share, leaving 923.714 shares of common stock directly owned after the transaction.
Ecolab Inc. executive stock option grant disclosed
Ecolab Inc. reported that an executive officer, serving as EVP, General Counsel and Secretary, received a new employee stock option award on December 3, 2025. The option gives the right to buy 5,954 shares of Ecolab common stock at an exercise price of $268.515 per share.
The option is structured to vest in stages. It becomes exercisable, on a cumulative basis, as to one-third of the option shares on each of the first and second anniversaries of the grant date, and the remaining shares vest on the third anniversary. The option is first exercisable on December 3, 2026 and expires on December 3, 2035.
Ecolab Inc. executive Nicholas J. Alfano, EVP & President – Global Water, reported a new equity award and updated holdings. On 12/03/2025, he received an employee stock option to buy 8,119 shares of Ecolab common stock at an exercise price of $268.515 per share. The option is exercisable in thirds on the first, second, and third anniversaries of the grant date and expires on 12/03/2035.
Following the reported transactions, Alfano directly holds 4,718.139 shares of Ecolab common stock, including shares accumulated through automatic dividend reinvestment. He also holds 1,477.031 units in the Ecolab Stock Fund within the company’s 401(k) savings plan as of 11/30/2025, which are equivalent to approximately 2,710 shares of Ecolab common stock.
Ecolab Inc. reported a routine insider equity award for executive Margeaux King, who serves as EVP - Human Resources. On 12/03/2025, King received an employee stock option grant covering 6,495 shares of Ecolab common stock with an exercise price of $268.515 per share.
The options begin to vest on a cumulative basis as to one-third of the shares on the first and second anniversaries of the grant date, with the remaining shares vesting on the third anniversary. The first exercisable date is 12/03/2026, and the options expire on 12/03/2035. The filing indicates King holds these derivative securities in direct ownership.
Ecolab Inc. executive stock holdings and option grant disclosed
Ecolab Inc. (ticker ECL) reported a Form 4 for an officer serving as Executive Vice President and President of the Institutional Group. Following the reported transactions, the officer beneficially owns 9,070.38 shares of Ecolab common stock directly and 3,532.48 units in the Ecolab Stock Fund through the Ecolab Savings Plan, which the explanation notes are equivalent to approximately 6,481 shares of common stock as of November 30, 2025.
The filing also shows a new employee stock option grant covering 8,661 shares of Ecolab common stock at an exercise price of $268.515 per share, dated December 3, 2025. These options become exercisable in three annual installments: one-third on each of the first and second anniversaries of the grant date and the remaining shares on the third anniversary, with a final expiration date of December 3, 2035.
Ecolab Inc. reported an equity award for its Chief Financial Officer, who is a reporting officer of the company. On 12/03/2025, the CFO acquired an employee stock option covering 15,697 shares of Ecolab common stock with an exercise price of $ 268.515 per share. These options are scheduled to become exercisable in stages: one-third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, with a final expiration date of 12/03/2035.
After this transaction, the CFO beneficially owned 11,529.846 shares of common stock directly, plus 1,442.291 UNITS in the Ecolab Stock Fund of the Ecolab Savings Plan as of November 30, 2025. Those UNITS include 6.887 UNITS acquired since the prior report and are described as being equivalent to approximately 2,646 shares of Ecolab common stock.
Ecolab Inc. reported an insider equity award for its President & COO, Darrell R. Brown. On 12/03/2025, he received an employee stock option to purchase 16,780 shares of Ecolab common stock at an exercise price of $268.515 per share. The option becomes exercisable in stages: one-third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, and is listed as first exercisable on 12/03/2026 and expiring on 12/03/2035.
After this reported transaction, Brown is shown as directly beneficially owning 27,528.563 shares of Ecolab common stock and holding 16,780 stock options. This filing documents his equity-based compensation and current reported ownership position as a senior executive.
Ecolab Inc. executive Alexander A. De Boo, EVP & President – Global Markets, reported equity transactions in Ecolab Inc. (ticker ECL). On 11/24/2025, he exercised an employee stock option covering 2,153 shares of common stock at an exercise price of $119.12 per share and acquired those shares. The option was originally granted under the Ecolab Inc. 2010 Stock Incentive Plan and had become exercisable in three annual installments beginning on 12/02/2016.
On the same date, he sold 1,422 shares of Ecolab common stock at a price of $268.25 per share. After these transactions, he beneficially owned 5,725.604 shares of Ecolab common stock in direct ownership.